These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23692432)

  • 1. Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas.
    Sakashita T; Homma A; Suzuki S; Hatakeyama H; Kano S; Mizumachi T; Oridate N; Fukuda S
    Acta Otolaryngol; 2013 Sep; 133(9):984-91. PubMed ID: 23692432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
    Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
    Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy.
    Higuchi E; Oridate N; Homma A; Suzuki F; Atago Y; Nagahashi T; Furuta Y; Fukuda S
    Head Neck; 2007 Oct; 29(10):940-7. PubMed ID: 17563903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence.
    Sawair F; Hassona Y; Irwin C; Stephenson M; Hamilton P; Maxwell P; Gordon D; Leonard A; Napier S
    Asian Pac J Cancer Prev; 2016; 17(3):1243-9. PubMed ID: 27039754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.
    Singh J; Jayaraj R; Baxi S; Mileva M; Curtin J; Thomas M
    Asian Pac J Cancer Prev; 2013; 14(8):4717-21. PubMed ID: 24083732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
    Brennan JA; Mao L; Hruban RH; Boyle JO; Eby YJ; Koch WM; Goodman SN; Sidransky D
    N Engl J Med; 1995 Feb; 332(7):429-35. PubMed ID: 7619114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma.
    Rasamny JJ; Allak A; Krook KA; Jo VY; Policarpio-Nicolas ML; Sumner HM; Moskaluk CA; Frierson HF; Jameson MJ
    Otolaryngol Head Neck Surg; 2012 Jun; 146(6):923-31. PubMed ID: 22323434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancer.
    Ko E; Kim Y; Cho EY; Han J; Shim YM; Park J; Kim DH
    Ann Surg Oncol; 2013 Mar; 20(3):1005-12. PubMed ID: 23115005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ki67, p53 and cyclin D1 in the squamous cell carcinoma of head and neck].
    Golusiński W; Golusiński P; Stańczak J; Kłosin J
    Otolaryngol Pol; 2004; 58(4):777-84. PubMed ID: 15603389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
    Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL
    Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
    Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
    Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ
    ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
    Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
    Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistochemical study of cyclin D1 protein expression in laryngeal squamous cell carcinoma.
    Morshed K; Skomra D; Korobowicz E; Szymański M; Polz-Dacewicz M; Gołabek W
    Acta Otolaryngol; 2007 Jul; 127(7):760-9. PubMed ID: 17573573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
    Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
    Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
    van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
    Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.